The Endocannabinoid System & Nutrigenomics
Wednesday, May 4, 2022
The endocannabinoid (eCB) system consists of receptors, endogenous ligands and ligand metabolic enzymes, and represents a microcosm of psychoneuroimmunology, or mind-body medicine. Suboptimal functioning of the eCB system with deficient eCB signaling appears to be involved in the pathogenesis of numerous diseases, with research suggesting that Clinical Endocannabinoid Deficiency Syndrome plays a role in migraine, fibromyalgia, irritable bowel syndrome, and depressive illnesses. Supporting the eCB may be accomplished via at least three molecular mechanisms: 1) augmenting eCB ligand biosynthesis; 2) decreasing eCB ligand degradation; and 3) augmenting or decreasing receptor density or function.
This webinar will cover the use of personalized genetic tools that translate genomic data into practical lifestyle and nutritional recommendations, to identify SNP variants that impact key biochemical pathways relevant to the eCB system and develop treatment plans that support optimal function.
- The role of the Endocannabinoid System (ECS), receptors and the mechanism of action of endocannabinoids
- Key biochemical and receptor signalling pathways that can be identified and addressed with nutrigenomics
- Signs and symptoms to confirm phenotypic expression of SNPs
- Supplementation strategies to address SNPs in these core pathways
A .pdf file will be emailed prior to the live webinar.